Reconnect Labs
Z├╝rich
About Reconnect Labs
Reconnect Labs is a clinical stage biopharmaceutical company specializing in neuropsychiatry. The company focuses on the development of next-generation psychedelic medicines. Utilizing Swiss precision design, Reconnect Labs aims to address unmet medical needs in mental health through innovative small molecule drugs. The company is involved in multiple clinical trials and leverages a robust technology platform to advance its therapeutic pipeline.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $24.0M
- Funding stage: Early Stage Venture
- Last round: Grant (Jan 2025)
- Website: reconnect-labs.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Medical, Psychology
Social Profiles
Canonical: https://fsome.com/organization/reconnect-labs-117274 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.